Focus on Fulcrum’s FSHD tissue modeling project

Cambridge, Massachusetts, biotech company Fulcrum Therapeutic’s research program on FSH muscular dystrophy was featured in Clinical Leader yesterday. The company “is using tissue donated from patients with facioscapulohumeral (FSH) muscular dystrophy, an incurable form of the disease, to find a treatment,” the article reported. “The tissue is used to create research models that look and respond … Read more of “Focus on Fulcrum’s FSHD tissue modeling project” »

Last 2017 Watch is out!

Our last Watch issue of 2017 is available now! Highlights include: Team FSHD Cycling participating in the 36th Race Across America An introduction to new FSH Society CEO, Mark Stone San Francisco FSHD Family Day Human growth hormone and testosterone as a potential treatment for FSHD A new genetic mouse model for testing FSHD treatments … Read more of “Last 2017 Watch is out!” »

Recent FSHD research publications

Notable findings and advances from the past six months by DANIEL PAUL PEREZ Chief Science Officer, FSH Society Asterisk denotes FSH Society funding acknowledged in paper. “Conservation and innovation in the DUX4-family gene network,” from the laboratory of Stephen J. Tapscott at the Fred Hutchinson Cancer Center in Seattle, Washington (Whiddon et al. Nat Genet. … Read more of “Recent FSHD research publications” »

Blazing a Trail to the Future

You inspire me! You have faithfully supported, worked, and engaged your network and loved ones to join our quest for treatments and a cure for FSHD. I want to acknowledge our deep appreciation for your past support and generosity. Many of the advancements of this year would not have been possible without you. It has … Read more of “Blazing a Trail to the Future” »

An undeniable sense of optimism

In this interview, Dr. Jeffery Statland of the University of Kansas Medical Center explains how FSH Society funding seeded the creation of the seven-site Clinical Trial Research Network (CTRN), which in turn led to the largest clinical trial preparedness study that has ever been run in the United States. We have entered a convergence zone―a … Read more of “An undeniable sense of optimism” »

A comedian’s worst nightmare

Watch what happens with this famous Dutch comedian performs before an audience of people with facioscapulohumeral muscular dystrophy.  Did you notice confidence and determination of these patients and families, boldly demanding recognition and action on FSHD? We know the direction we need to go. That’s why you can donate with confidence to the FSH Society’s … Read more of “A comedian’s worst nightmare” »

Thank you

It is because of your donations and support that we are advancing towards treatments and healthier lives for everyone with FSH muscular dystrophy.  This Thanksgiving, we are grateful for you and the difference you are making in countless lives.   With gratitude from the FSH Society Team,

#GivingTuesday 2017 is Just Around the Corner!

Join us on Tuesday, November 28th, 2017 as we participate in the 6th annual #GivingTuesday! #GivingTuesday is a global day of giving fueled by social media and collaboration following the widely recognized shopping days of Black Friday and Cyber Monday. Known as the unofficial kickoff to the giving season, every year philanthropies are celebrated and communities … Read more of “#GivingTuesday 2017 is Just Around the Corner!” »

Placing a BET on blocking DUX4

by FRAN SVERDRUP, PHD St. Louis, Missouri DUX4 is considered to be a key cause of muscle degeneration in FSH muscular dystrophy. This is why we are interested in finding drugs that “turn off” the production of DUX4, which would prevent the many detrimental activities of this toxic protein. Such drugs would potentially provide the … Read more of “Placing a BET on blocking DUX4” »